AU2002320199A1 - Purine derivatives as a2b adenosine receptor antagonists - Google Patents

Purine derivatives as a2b adenosine receptor antagonists

Info

Publication number
AU2002320199A1
AU2002320199A1 AU2002320199A AU2002320199A AU2002320199A1 AU 2002320199 A1 AU2002320199 A1 AU 2002320199A1 AU 2002320199 A AU2002320199 A AU 2002320199A AU 2002320199 A AU2002320199 A AU 2002320199A AU 2002320199 A1 AU2002320199 A1 AU 2002320199A1
Authority
AU
Australia
Prior art keywords
receptor antagonists
adenosine receptor
purine derivatives
purine
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002320199A
Inventor
Venkata Palle
Vaibhav Varkhedkar
Dengming Xiao
Jeff A. Zablocki
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Gilead Palo Alto Inc
Original Assignee
CV Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by CV Therapeutics Inc filed Critical CV Therapeutics Inc
Publication of AU2002320199A1 publication Critical patent/AU2002320199A1/en
Abandoned legal-status Critical Current

Links

AU2002320199A 2001-06-29 2002-06-27 Purine derivatives as a2b adenosine receptor antagonists Abandoned AU2002320199A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US60/302,208 2001-06-29

Publications (1)

Publication Number Publication Date
AU2002320199A1 true AU2002320199A1 (en) 2003-03-03

Family

ID=

Similar Documents

Publication Publication Date Title
HUP0401925A3 (en) A2b adenosine receptor antagonists
AU5316000A (en) Substituted 8-phenylxanthines useful as antagonists of a2b adenosine receptors
IL175759A0 (en) A2b adenosine receptor antagonists
IL161572A0 (en) Adenosine a2a receptor antagonists
IL152726A0 (en) Adenosine a2a receptor antagonists
IL161716A0 (en) ADENOSINE A2a RECEPTOR ANTAGONISTS
IL174771A0 (en) Pyrimidin-2-amine derivatives and their use as a2b adenosine receptor antagonists
IL158214A0 (en) 8-heteroaryl xanthine adenosine a2b receptor antagonists
AU5640199A (en) 4-quinolinemethanol derivatives as purine receptor antagonists (i)
PL377632A1 (en) Antiviral nucleoside derivatives
AU2002327168A1 (en) Pyrrolo(2,3-d)pyrimidine nucleoside analogs
AU5640299A (en) 4-quinolinemethanol derivatives as purine receptor antagonists.(ii)
HRP20050540A2 (en) Imidazoquinoline derivatives as adenosine a3 receptor ligands
HK1064097A1 (en) Bicyclic Ä1,2,4Ü -triazole adenosine a2a receptor antagonists
PL373953A1 (en) 7-amino-benzothiazole derivatives as adenosine receptor ligands
AU2003231805A1 (en) Purine derivatives as liver x receptor agonists
HUP0400530A3 (en) Condensed purine derivatives as a1 adenosine receptor antagonists
AU2003301589A1 (en) Purine nucleosides
HUP0303533A3 (en) Adenosine a1 agonist adenosine derivatives
HRP20040672A2 (en) Triazolo-quinolin derivatives useful as adenosine receptor ligands
PL370565A1 (en) 5-methoxy-8-aryl-[1,2,4] triazolo [1,5-a] pyridine derivatives as adenosine receptor antagonists
AU2002356369A1 (en) Xanthine derivatives as muscarinic receptor antagonists
AU2003296601A1 (en) Antiviral nucleoside derivatives
AU2002320199A1 (en) Purine derivatives as a2b adenosine receptor antagonists
SI1401837T1 (en) Purine derivatives as a2b adenosine receptor antagonists